在和发作疾病中使用大麻素治疗
Orrin Devinsky1,2,3, Nicholas A Jones4, Mark O Cunningham5
1Department of Neurology, NYU Grossman School of Medicine, New York, New York, United States.
Physiological reviews
|October 26, 2023
概括
包括大麻 (CBD) 在内的大麻素显示出治疗和发作的治疗潜力. 本综述检查了他们在临床前和临床研究中的抗作用,支持CBD.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 大麻素科学 大麻素科学
背景情况:
- 大麻在历史上曾被用于治疗.
- 像CBD这样的大麻素显示出治疗和神经系统疾病的前景.
- 大麻 (CBD) 是FDA批准用于特定类型的.
研究的目的:
- 综合审查大麻素在中的作用.
- 评估当前的理解和确定研究差距.
- 探索大麻素在神经和精神疾病中的治疗潜力.
主要方法:
- 关于急性发作和慢性发作的临床前动物研究的综述.
- 分析临床文献,包括事报告,病例研究和随机对照试验.
- 在中枢神经系统中检查大麻素作用的生理机制.
主要成果:
- 大麻素,特别是CBD,表现出抗发作作用.
- 临床前和临床数据支持大麻素在的治疗作用.
- 随机对照试验导致FDA批准CBD用于某些类型的.
结论:
- 大麻素,特别是CBD,在治疗中具有重要意义.
- 需要进一步的研究来解决关于大麻素机制和应用的未解答问题.
- 该审查综合了关于的大麻素的证据,指导了未来的调查.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
425
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
425
Antiepileptic Drugs: Glutamate Antagonists
383
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
383
Antiepileptic Drugs: Sodium Channel Blockers
611
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
611
Arteries of the Lower Limbs
194
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
194
Antiepileptic Drugs: Calcium Channel Blockers
418
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
418
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
318
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
318


